0001821223-22-000001.txt : 20220718 0001821223-22-000001.hdr.sgml : 20220718 20220718101717 ACCESSION NUMBER: 0001821223-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220718 DATE AS OF CHANGE: 20220718 EFFECTIVENESS DATE: 20220718 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kinaset Therapeutics, Inc. CENTRAL INDEX KEY: 0001821223 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-452720 FILM NUMBER: 221088494 BUSINESS ADDRESS: STREET 1: 10 KNOLLWOOD ROAD CITY: MEDFIELD STATE: MA ZIP: 02052 BUSINESS PHONE: (508) 858-5810 MAIL ADDRESS: STREET 1: 10 KNOLLWOOD ROAD CITY: MEDFIELD STATE: MA ZIP: 02052 D 1 primary_doc.xml X0708 D LIVE 0001821223 Kinaset Therapeutics, Inc. 10 KNOLLWOOD ROAD MEDFIELD MA MASSACHUSETTS 02052 (508) 858-5810 DELAWARE None None Corporation true 2020 Robert Clarke 10 Knollwood Road Medfield MA MASSACHUSETTS 02052 Executive Officer Director Promoter Chief Executive Officer Jamil Beg 10 Knollwood Road Medfield MA MASSACHUSETTS 02052 Director Kevin Bitterman 10 Knollwood Road Medfield MA MASSACHUSETTS 02052 Director Tom King 10 Knollwood Road Medfield MA MASSACHUSETTS 02052 Director Bram Vanparys 10 Knollwood Road Medfield MA MASSACHUSETTS 02052 Director Roger Heerman 10 Knollwood Road Medfield MA MASSACHUSETTS 02052 Executive Officer Promoter Chief Business Officer and Chief Operating Officer Frazer Morgan 10 Knollwood Road Medfield MA MASSACHUSETTS 02052 Executive Officer Promoter Chief Development Officer Pharmaceuticals Decline to Disclose 06b false 2022-07-05 true true true true false 7125000 41000000 28500000 12500000 Investors funded $15MM, agreed to fund an additional $13.5MM and have the option to acquire an additional $12.5MM. false 3 0 0 0 false Kinaset Therapeutics, Inc. /s/ Robert Clarke Robert Clarke Chief Executive Officer 2022-07-18